Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Research and Markets
DUBLIN, February 14, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/ttlq24/advances_in_gene) has announced the addition of the "Advances in Gene Expression Profiling (Technical Insights)" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The industry dynamics of gene expression profiling are constantly changing. There are novel technologies emerging with high throughput and more sensitivity. Currently gene expression profiling techniques are being utilized in drug discovery, clinical diagnostics and basic research. The applications areas of gene expression spans across communicable and non-communicable disease and goes far enough to cover lifestyle disorders such as obesity. Novel data management techniques are needed, due to frustrating challenges of lack of data storage options and uninterpretable raw genomic data which has led software companies to look at it as an investment hotspot.
Gene expression profiling encompasses a wide range of technologies, techniques and data informatics operations. The scientific understanding of gene expression profiling is to quantify the amount of mRNA and protein that is being expression in a sample or across multiple samples at any given time for populations. Methods such as microarray techniques, reverse transcription polymerase chain reaction (PCR) and RNA sequencing are constantly evolving and being adopted in healthcare and biotechnology towards the development of diagnostic and therapeutics assays, biomarkers, drug discovery and development, discovery of novel pathways in disease and understanding gene function and pathogenesis of diseases. These application areas are highly relevant especially in this era of personalized medicine." The relevance of gene expression profiling being used as a science for the development of therapeutic and diagnostic tools spans across several disease types such as cancer, cardiovascular disease, neurodegenerative disease in addition to a whole host of infectious diseases. It also plays a crucial role in prenatal screening and genetic testing space.
Managing the large amount of genomic data produced through expression profiling technologies such as microarrays and RNAsequencing is another area which is facing rapid growth. There are a plethora of opportunities emerging making genomic data management a hotbed for investors. Majority of the funds that seem to be coming into this sector have been going towards the development of data storage, analysis and visualization tools that can potentially eliminate the pertinent challenges present in the industry.
Key Topics Covered:
Technology Snapshot and Trends
Key Innovations, 2010 to 2013
Technology Value Chain
Industry Value Chain
Impact Assessment and Analysis
Market Impact of Business Challenges
Market Impact of Technology Challenges
Market Impact of Technology/Business Accelerators
Diffusion of Innovations and Need Assessment
Technology Adoption Scenario
Demand Side Needs
Opportunity Evaluation and Road mapping
Emerging Opportunities-For Stakeholders
Emerging Opportunities-For Investors
Gene Expression Profiling-Technology Trends Data Management
Technology Value Chain
Strategic Recommendations for Technology Investors
Key Patents and Contacts
The Frost & Sullivan Story
For more information visit http://www.researchandmarkets.com/research/ttlq24/advances_in_gene
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
©2012 PR Newswire. All Rights Reserved.